In this episode of Drug Digest, PharmTech editors discuss the changing environment that is facilitating greater acceptance of continuous manufacturing technologies as well as advances and challenges ...

Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...

ISA106 started with the goal of developing standards, recommended practices, and technical reports on the design and implementation of procedures for automating continuous process operations. The ...

In the manufacture of biotherapeutic drugs, the goal is to maximize production while minimizing costs, even though achieving this goal may involve a difficult transition—specifically, a transition ...

The guide reviews unit operations and establishes equipment requirements for continuous manufacturing of oral solid dosage forms. The International Society of Pharmaceutical Engineering (ISPE) ...

More and more drugmakers are giving continuous manufacturing a try, seeing it as the future in small molecule drug production, in part, because the plants for the process are much smaller than those ...

This workshop will discussed the business and regulatory concerns associated with adopting continuous manufacturing techniques to produce biologics, such as enzymes, monoclonal antibodies, and ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...

Continuous casting remains a critical process in modern steel production, whereby molten steel is poured into a mould and solidified into semi-finished forms such as blooms, billets or slabs. This ...